Drug profile · INN
mesalamine
MESALAMINE
mesalamine (MESALAMINE) is a arachidonate 5-lipoxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: rectal. Current US regulatory status: approved.
Drug details — mesalamine
- US status
- approved
- Class
- —
- Route
- RECTAL
- Patents
- 0
- Programs
- 13
- Data quality
- 0.89
Quick answer
mesalamine (MESALAMINE) is a arachidonate 5-lipoxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: rectal. Current US regulatory status: approved.
Key facts
Mechanism of action
Arachidonate 5-lipoxygenase inhibitor
Primary target: Polyunsaturated fatty acid 5-lipoxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is mesalamine?
mesalamine (MESALAMINE) is a arachidonate 5-lipoxygenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for mesalamine?
MESALAMINE is a marketed brand name for mesalamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mesalamine?
mesalamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.